Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2022-12-30 00:00:00 ET · period of report 2022-12-28 · accession 0001415889-22-013104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-30 | 2022-12-28+ | FENC | Raykov Rosty | CEO, Dir | S - Sale | $9.61 | -28.7K | 232.8K | -11% | -$276.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2022-12-30 | S | D | 8,400 | $9.61 | 217,838 | D | — | — | (F4) Shares were sold to pay taxes on share exercises on August 22, 2022 and September 9, 2022. |
| 2 | Common | Common shares | 2022-12-30 | S | D | 1,600 | $9.66 | 226,238 | D | — | — | (F3) Shares were sold to pay taxes on share exercises on August 22, 2022 and September 9, 2022. |
| 3 | Common | Common shares | 2022-12-29 | S | D | 5,000 | $9.65 | 227,838 | D | — | — | (F2) Shares were sold to pay taxes on share exercises on August 22, 2022 and September 9, 2022. |
| 4 | Common | Common shares | 2022-12-28 | S | D | 13,740 | $9.59 | 232,838 | D | — | — | (F1) Shares were sold to pay taxes on share exercises on August 22, 2022 and September 9, 2022. |